State Street’s Werewolf Therapeutics HOWL Stock Holding History

State Street’s Portfolio HOWL Stock Details HOWL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.9K	Hold	119,168	–	–	﹤0.01%	4075
2026 Q1	$99.2K	Hold	119,168	–	–	﹤0.01%	4027
2025 Q4	$75.5K	Hold	119,168	–	–	﹤0.01%	4094
2025 Q3	$235K	Hold	119,168	–	–	﹤0.01%	3866
2025 Q2	$130K	Sell	119,168 -325,104	-73%	-$335K	﹤0.01%	3925
2025 Q1	$432K	Buy	444,272 +17,500	+4%	+$22.9K	﹤0.01%	3626
2024 Q4	$632K	Sell	426,772 -49,667	-10%	-$101K	﹤0.01%	3574
2024 Q3	$1.01M	Buy	476,439 +52,528	+12%	+$119K	﹤0.01%	3484
2024 Q2	$1.03M	Buy	423,911 +352,743	+496%	+$1.69M	﹤0.01%	3470
2024 Q1	$461K	Sell	71,168 -12,300	-15%	-$71.7K	﹤0.01%	3670
2023 Q4	$322K	Buy	83,468 +32,700	+64%	+$83.5K	﹤0.01%	3759
2023 Q3	$109K	Hold	50,768	–	–	﹤0.01%	4093
2023 Q2	$155K	Hold	50,768	–	–	﹤0.01%	4084
2023 Q1	$132K	Buy	50,768 +17,800	+54%	+$53.1K	﹤0.01%	4229
2022 Q4	$67.6K	Buy	32,968 +8,400	+34%	+$22K	﹤0.01%	4480
2022 Q3	$111K	Hold	24,568	–	–	﹤0.01%	4432
2022 Q2	$100K	Sell	24,568 -310,519	-93%	-$1.42M	﹤0.01%	4536
2022 Q1	$1.47M	Buy	335,087 +75,461	+29%	+$529K	﹤0.01%	3671
2021 Q4	$3.09M	Buy	259,626 +143,562	+124%	+$2.17M	﹤0.01%	3475
2021 Q3	$1.99M	Buy	116,064 +37,827	+48%	+$645K	﹤0.01%	3614
2021 Q2	$1.36M	Buy	+78,237	New	+$1.07M	﹤0.01%	3614

Other funds holding HOWL

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return

Verdad Advisers Boston, Massachusetts $104M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street's HOWL Position: Q2 2026 in Review

State Street held its Werewolf Therapeutics (HOWL) position steady in Q2 2026 at 119,168 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4075.

State Street first reported a position in HOWL in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.09M in Q4 2021. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

State Street held 119,168 shares of Werewolf Therapeutics worth $42.9K as of Q2 2026.
State Street left its Werewolf Therapeutics share count unchanged in Q2 2026.
Werewolf Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4075 holding.
State Street first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 21 quarters since.
State Street's Werewolf Therapeutics position peaked at $3.09M in Q4 2021.
45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.